Position Purpose This role will lead portfolio/brand strategy and implementation for multiple assets, Xeljanz RA and UC and Etrasimod as a new launch expected in 2025, which contribute Specialty Care business growth in the next 3-5
Do you want to play a crucial role in maximizing patient reach and enhancing value in the Cardiometabolic therapeutic area? Do you want to be part of a team that is at the forefront of innovation,